Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study for the Use of Vidaza™ to Restore Responsiveness of Patients' Prostate Cancers to Hormonal Therapy

NCT00384839 is registered in ClinicalTrials.gov with US Oncology Research as lead sponsor.

NCT NCT00384839
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00384839 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study for the Use of Vidaza™ to Restore Responsiveness of Patients' Prostate Cancers to Hormonal Therapy
Lead sponsor
US Oncology Research
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2006
Completion date
November 30, 2009
Enrollment
36 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer